United Therapeutics Corporation · NASDAQ:UTHR

Patusky Christopher sold 2,910 United Therapeutics Corporation shares (Form 4)

Traded Apr 24, 2026 · Filed Apr 24, 2026

On Apr 24, 2026, Patusky Christopher (Director) sold 2,910 United Therapeutics Corporation shares at US$569.00 for US$1.66M under a trading plan, leaving 1,490 shares. Filed Apr 24, 2026 (Form 4).

Sold
2,910 shares
Price
US$569.00
Value
US$1.66M
Holding after
1,490 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 24, 2026Common StockOption exercise2,910US$101.804,400Direct
Apr 24, 2026Common StockSale2,910US$569.001,490Direct

Source

View original at SEC

Related